OBJECTIVE: To assess direct healthcare resource utilization and costs in treatment-
adherent adult patients with epilepsy who experience breakthrough seizures treated in the …

Purpose The purpose of this study was to measure health-care resource utilization and costs
in treatment-adherent, previously seizure-free patients with epilepsy who were treated in the …

Objective: To quantify the clinical and economic burden of uncontrolled epilepsy in patients
requiring emergency department (ED) visit or hospitalization. Methods: Health insurance …

Objective To estimate the treatment gap between a new epilepsy diagnosis and antiepileptic
drug (AED) initiation in the United States. Methods Retrospective claims-based cohort study …

Objective To determine the association of a neurologist visit with health care use and cost
outcomes for patients with incident epilepsy. Methods Using health care claims data for …

Objective: This study aims to understand the management and treatment outcomes of
patients with drug-resistant focal onset seizures in the United States (US). Background: In …

OBJECTIVE: To evaluate real-world treatment persistence and failure of first-line (1L)
antiepileptic drug (AED) therapy among adult epilepsy patients. BACKGROUND …

Objective: To evaluate whether generic substitution was associated with any difference in
medical resource utilization for 5 widely used antiepileptic drugs (AEDs) in the United …

Our objective was to identify the top MD-office, inpatient and outpatient diagnoses,
procedures, drug classes, comorbidities, and cost of health care for people with epilepsy …

Despite the availability of numerous antiepileptic drugs (AEDs), some epilepsies remain
resistant to treatment. We compared utilization and costs in patients with uncontrolled …